So-called passenger mutations, such as some JAK3 kinase domain mutations and the majority of mutations in the FERM/SH2 domain of JAK3, do not contribute to cellular transformation nor leukemia development [84,94,95,96]. The gene discussed is JAK3; the disease is leukemia.